{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:29:24Z","timestamp":1764332964853,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Paul and Anna Shockey Family Foundation"},{"name":"LDN fund"},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR002014"],"award-info":[{"award-number":["UL1 TR002014"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.brainresbull.2020.10.015","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T21:31:17Z","timestamp":1603488677000},"page":"246-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["[Met5]-enkephalin preserves diffusion metrics in EAE mice"],"prefix":"10.1016","volume":"165","author":[{"given":"Chirag","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Meadowcroft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian S.","family":"Zagon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia J.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2020.10.015_bib0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainresbull.2018.01.015","article-title":"Principles of diffusion kurtosis imaging and its role in early diagnosis of neurodegenerative disorders","volume":"139","author":"Arab","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0010","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/WCO.0000000000000319","article-title":"Multiple sclerosis: genetics, biomarkers, treatments","volume":"29","author":"Axisa","year":"2016","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0015","first-page":"111","article-title":"Induction of experimental autoimmune enchephalomyelitis in mice and evaluation of the disease-dependent distribution of immune cells in various tissues","author":"Barthelmes","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0020","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00439-015-1601-2","article-title":"A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches","volume":"134","author":"Bashinskaya","year":"2015","journal-title":"Hum. Genet."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0025","article-title":"Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice","volume":"86","author":"Bittner","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0030","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/jnr.24224","article-title":"Animal models of multiple sclerosis: focus on experimental autoimmune encephalomyelitis","volume":"96","author":"Bjelobaba","year":"2018","journal-title":"J. Neurosci. Res."},{"year":"2009","series-title":"Neurobiology of Disease Axial Diffusivity is the Primary Correlate of Axonal Injury in the Experimental Autoimmune Encephalomyelitis Spinal Cord: A Quantitative Pixelwise Analysis","author":"Budde","key":"10.1016\/j.brainresbull.2020.10.015_bib0035"},{"year":"2012","series-title":"Opioid Growth Factor Arrests the Progression of Clinical Disease and Spinal Cord Pathology in Established Experimental Autoimmune Encephalomyelitis","author":"Campbell","key":"10.1016\/j.brainresbull.2020.10.015_bib0040"},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0045","first-page":"12","article-title":"Advances in brain imaging in multiple sclerosis","author":"Cortese","year":"2019","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0055","first-page":"11","article-title":"High-resolution diffusion tensor spinal cord MRI measures as biomarkers of disability progression in a rodent model of progressive multiple sclerosis","author":"Gilli","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.brainresbull.2013.08.001","article-title":"Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor","volume":"98","author":"Hammer","year":"2013","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1535370215596384","article-title":"Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4+ T lymphocytes in established experimental autoimmune encephalomyelitis a model of multiple sclerosis","volume":"241","author":"Hammer","year":"2016","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0070","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1177\/1352458517694432","article-title":"New insights into the burden and costs of multiple sclerosis in Europe","volume":"23","author":"Kobelt","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0075","first-page":"1","article-title":"The spectrum of spinal cord lesions in a primate model of multiple sclerosis","author":"Lefeuvre","year":"2019","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2017.06.015","article-title":"Elevated serum [Met5]-enkephalin levels correlate with improved clinical and behavioral outcomes in experimental autoimmune encephalomyelitis","volume":"134","author":"Ludwig","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0085","first-page":"1","article-title":"Serum [Met5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone","volume":"0","author":"Ludwig","year":"2017","journal-title":"Exp. Biol. Med."},{"year":"2012","series-title":"Endogenous Opioid Inhibition of Proliferation of T and B Cell Subpopulations in Response to Immunization for Experimental Autoimmune Encephalomyelitis","author":"McLaughlin","key":"10.1016\/j.brainresbull.2020.10.015_bib0090"},{"year":"2020","series-title":"Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia","author":"Parkitny","key":"10.1016\/j.brainresbull.2020.10.015_bib0095"},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0100","series-title":"Multiple Chronic Conditions \u2013 Overview and Management of Chronic Disease Clusters [Working Title]","article-title":"Enkephalin therapy improves relapsing-remitting multiple sclerosis","author":"Patel","year":"2020"},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40120-018-0103-2","article-title":"Monitoring progressive multiple sclerosis with novel imaging techniques","volume":"7","author":"Petracca","year":"2018","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0115","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2015.03.042","article-title":"Animal models of multiple sclerosis","volume":"759","author":"Procaccini","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.brainres.2011.01.036","article-title":"Prevention and diminished expression of experimental autoimmune enchephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: therapeutic implications for multiple sclerosis","volume":"1381","author":"Rahn","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neulet.2011.03.021","article-title":"Spinal cord histopathology of MOG peptide 35-55-induced experimental autoimmune encephalomyelitis is time and score dependent","volume":"494","author":"Recks","year":"2011","journal-title":"Neurosci. Lett."},{"year":"2014","series-title":"The Experimental Autoimmune Encephalomyelitis (EAE) Model of MS: Utility for Understanding Disease Pathophysiology and Treatment","author":"Robinson","key":"10.1016\/j.brainresbull.2020.10.015_bib0130"},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nic.2008.08.001","article-title":"Diffusion tensor MR imaging","volume":"19","author":"Rovaris","year":"2009","journal-title":"Neuroimaging Clin. N. Am."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0140","doi-asserted-by":"crossref","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0145","first-page":"7","article-title":"A hitchhiker\u2019s guide to diffusion tensor imaging","author":"Soares","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0150","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.neuroimage.2003.07.005","article-title":"Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia","volume":"20","author":"Song","year":"2003","journal-title":"Neuroimage"},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0155","doi-asserted-by":"crossref","first-page":"W26","DOI":"10.2214\/AJR.13.11365","article-title":"Diffusion kurtosis imaging: an emerging technique for evaluating the microstructural environment of the brain","volume":"202","author":"Steven","year":"2014","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0160","first-page":"6","article-title":"Low-dose naltrexone (LDN)-review of therapeutic utilization","author":"Toljan","year":"2018","journal-title":"Med. Sci."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0165","article-title":"The effect of inflammation on DTI derived axial and radial diffusivity: a Monte Carlo simulation study","volume":"19","author":"Wang","year":"2011","journal-title":"Proc. 19th Sci. Meet. Int. Soc. Magn. Reson. Med."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0170","series-title":"Brain","first-page":"3587","article-title":"Quantification of increased cellularity during inflammatory demyelination","author":"Wang","year":"2011"},{"year":"2020","series-title":"Diffusion Tensor Imaging Detects Treatment Effects of FTY720 in Experimental Autoimmune Encephalomyelitis Mice","author":"Wang","key":"10.1016\/j.brainresbull.2020.10.015_bib0175"},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0180","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrneurol.2015.157","article-title":"MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis \u2013 establishing disease prognosis and monitoring patients","volume":"11","author":"Wattjes","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0185","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00092","article-title":"Understanding the physiopathology behind axial and radial diffusivity changes-what do we know?","volume":"9","author":"Winklewski","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0190","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.imbio.2010.09.014","article-title":"T lymphocyte proliferation is suppressed by the opioid growth factor ([Met5]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases","volume":"216","author":"Zagon","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.brainresbull.2020.10.015_bib0195","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainres.2009.11.026","article-title":"Opioid growth factor suprpesses expression of experimental autoimmune encehphalomyelitis","volume":"1310","author":"Zagon","year":"2010","journal-title":"Brain Res."},{"year":"2020","series-title":"Molecular Biomarkers in Multiple Sclerosis","author":"Ziemssen","key":"10.1016\/j.brainresbull.2020.10.015_bib0200"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923020306730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923020306730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:44:56Z","timestamp":1759783496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923020306730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":40,"alternative-id":["S0361923020306730"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2020.10.015","relation":{},"ISSN":["0361-9230"],"issn-type":[{"type":"print","value":"0361-9230"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Met5]-enkephalin preserves diffusion metrics in EAE mice","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2020.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}